Popular anti-diabetes drug teneligliptin, insulin glargine injection, Common antibiotics like meropenem, Cefuroxime have been included in t...

The SEC on Covid-19 permitted the company to conduct phase-II trials with caveats such as that the participants should not be more than 65 ...

Natco Pharma launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcin...

Instead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by a different virus.

The issue received bids for 62,09,420 shares as against 2,19,11,308 on offer, data available with the stock exchanges till 5 pm showed.

The agreement sub-licenses Zydus to produce and sell daclatasvir in 112 low and middle income countries, it added.

Between 130 and 150 million people worldwide are estimated to have HCV. The vast majority lives in low and middle income countries, it adde...

And that's just one leukaemia drug. India's generic industry has been producing many such life-saving medicines at a fraction of the global...

Typically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the ...

Daclatasvir, discovered and developed by Bristol-Myer Squibb, is the first-in-class NS5A inhibitor used in combination with Sofosbuvir to t...

There might be more companies who might join the patent pool for the drug. Daclatasvir is known to cure multiple genotypes of the Hep C vir...

If scaling up of HIV treatment globally was made possible by Indian generics companies, it looks like they are set to repeat this feat with...

Daclatasvir in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections, which is highly prevalent i...

Natco Pharma has got approval from the Drugs Controller General of India (DCGI) to sell generic version of Daclatasvir, which is used for t...

India is now one of the few countries where generics are available for interferon-free treatment of Hepatitis C.

The move opens the way to improve access to innovative medicines that show clear clinical benefits and could have enormous public health im...

Results were similar in study participants infected with genotypes 2 or 3, strains which are less common in the US.